Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin
AbstractChemotherapy drugs for oral cancers always cause side effects and adverse effects. Currently natural sources and herbs are being searched for treated human oral squamous carcinoma cells (OSCC) in an effort to alleviate the causations of agents in oral cancers chemotherapy. This study investigates the effect of prodigiosin (PG), an alkaloid and natural red pigment as a secondary metabolite of Serratia marcescens, to inhibit human oral squamous carcinoma cell growth; thereby, developing a new drug for the treatment of oral cancer. In vitro cultured human OSCC models (OECM1 and SAS cell lines) were used to test the inhibitory growth of PG via cell cytotoxic effects (MTT assay), cell cycle analysis, and Western blotting. PG under various concentrations and time courses were shown to effectively cause cell death and cell-cycle arrest in OECM1 and SAS cells. Additionally, PG induced autophagic cell death in OECM1 and SAS cells by LC3-mediated P62/LC3-I/LC3-II pathway at the in vitro level. These findings elucidate the role of PG, which may target the autophagic cell death pathways as a potential agent in cancer therapeutics. View Full-Text
Share & Cite This Article
Cheng, M.-F.; Lin, C.-S.; Chen, Y.-H.; Sung, P.-J.; Lin, S.-R.; Tong, Y.-W.; Weng, C.-F. Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin. Mar. Drugs 2017, 15, 224.
Cheng M-F, Lin C-S, Chen Y-H, Sung P-J, Lin S-R, Tong Y-W, Weng C-F. Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin. Marine Drugs. 2017; 15(7):224.Chicago/Turabian Style
Cheng, Ming-Fang; Lin, Chun-Shu; Chen, Yu-Hsin; Sung, Ping-Jyun; Lin, Shian-Ren; Tong, Yi-Wen; Weng, Ching-Feng. 2017. "Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin." Mar. Drugs 15, no. 7: 224.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.